human embryonic stem cells
NewStem Files FDA De Novo Submission, Gets CE Mark for Stem Cell Mutational Analysis Software
The NewStem Software Diagnostic Device screens human haploid embryonic stem cells for gene mutations involved in chemotherapy resistance.
Precision Medicine Firm NewStem Secures $4M Funding Commitment
NewStem is developing a technology that uses human haploid embryonic stem cells to predict cancer drug resistance.